Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 11/2016

02.08.2016 | Clinical Investigation

Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To quantify the arterial flow change during transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) using digital subtraction angiography, quantitative color-coding analysis (d-QCA), and real-time subtraction fluoroscopy QCA (f-QCA).

Materials and Methods

This prospective study enrolled 20 consecutive patients with HCC who had undergone TACE via a subsegmental approach between February 2014 and April 2015. The TACE endpoint was a sluggish antegrade tumor-feeding arterial flow. d-QCA and f-QCA were used for determining the relative maximal density time (rTmax) of the selected arteries. The rTmax of the selected arteries was analyzed in d-QCA and f-QCA before and after TACE, and its correlation in both analyses was evaluated.

Results

The pre- and post-TACE rTmax of the embolized segmental artery in d-QCA and f-QCA were 1.59 ± 0.81 and 2.97 ± 1.80 s (P < 0.001) and 1.44 ± 0.52 and 2.28 ± 1.02 s (P < 0.01), respectively. The rTmax of the proximal hepatic artery did not significantly change during TACE in d-QCA and f-QCA. The Spearman correlation coefficients of the pre- and post-TACE rTmax of the embolized segmental artery between d-QCA and f-QCA were 0.46 (P < 0.05) and 0.80 (P < 0.001). Radiation doses in one series of d-QCA and f-QCA were 140.7 ± 51.5 milligray (mGy) and 2.5 ± 0.7 mGy, respectively.

Conclusions

f-QCA can quantify arterial flow changes with a higher temporal resolution and lower radiation dose. Flow quantification of the embolized segmental artery using f-QCA and d-QCA is highly correlated.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2002;55:74–108.CrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2002;55:74–108.CrossRef
2.
Zurück zum Zitat Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9.CrossRefPubMed Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9.CrossRefPubMed
3.
Zurück zum Zitat Lo C-M, Ngan H, Tso W-K, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71.CrossRefPubMed Lo C-M, Ngan H, Tso W-K, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71.CrossRefPubMed
4.
Zurück zum Zitat Jin B, Wang D, Lewandowski RJ, Ryu RK, Sato KT, Larson AC, et al. Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints. Am J Roentgenol. 2011;197(5):1237–43.CrossRef Jin B, Wang D, Lewandowski RJ, Ryu RK, Sato KT, Larson AC, et al. Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints. Am J Roentgenol. 2011;197(5):1237–43.CrossRef
5.
Zurück zum Zitat Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res. 2002;23(3):202–10.CrossRefPubMed Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res. 2002;23(3):202–10.CrossRefPubMed
6.
Zurück zum Zitat Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, et al. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology. 2004;66(1):24–31.CrossRefPubMed Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, et al. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology. 2004;66(1):24–31.CrossRefPubMed
7.
Zurück zum Zitat Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, et al. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Am J Roentgenol. 2010;194(3):830–7.CrossRef Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, et al. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Am J Roentgenol. 2010;194(3):830–7.CrossRef
8.
Zurück zum Zitat Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. Am J Roentgenol. 2011;196(4):919–28.CrossRef Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. Am J Roentgenol. 2011;196(4):919–28.CrossRef
9.
Zurück zum Zitat Kim YB, Park YN, Park C. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology. 2001;38(2):160–6.CrossRefPubMed Kim YB, Park YN, Park C. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology. 2001;38(2):160–6.CrossRefPubMed
10.
Zurück zum Zitat Poon RT, Lau C, Yu WC, Fan ST, Wong J. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. Oncol Rep. 2004;11(5):1077–84.PubMed Poon RT, Lau C, Yu WC, Fan ST, Wong J. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. Oncol Rep. 2004;11(5):1077–84.PubMed
11.
Zurück zum Zitat Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol. 2008;103(4):914–21.CrossRefPubMed Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol. 2008;103(4):914–21.CrossRefPubMed
12.
Zurück zum Zitat Lin YY, Lee RC, Tseng HS, Liu CA, Guo WY, Chang CY. Objective measurement of arterial flow before and after transcatheter arterial chemoembolization: a feasibility study using quantitative color-coding analysis. Cardiovasc Intervent Radiol. 2015;38(6):1494–501.CrossRefPubMed Lin YY, Lee RC, Tseng HS, Liu CA, Guo WY, Chang CY. Objective measurement of arterial flow before and after transcatheter arterial chemoembolization: a feasibility study using quantitative color-coding analysis. Cardiovasc Intervent Radiol. 2015;38(6):1494–501.CrossRefPubMed
13.
14.
Zurück zum Zitat Shpilfoygel SD, Close RA, Valentino DJ, Duckwiler GR. X-ray videodensitometric methods for blood flow and velocity measurement: a critical review of literature. Med Phys. 2000;27(9):2008–23.CrossRefPubMed Shpilfoygel SD, Close RA, Valentino DJ, Duckwiler GR. X-ray videodensitometric methods for blood flow and velocity measurement: a critical review of literature. Med Phys. 2000;27(9):2008–23.CrossRefPubMed
15.
Zurück zum Zitat Hodgson JM, LeGrand V, Bates ER, Mancini GB, Aueron FM, O’Neill WW, et al. Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization. Am J Cardiol. 1985;55(1):188–93.CrossRefPubMed Hodgson JM, LeGrand V, Bates ER, Mancini GB, Aueron FM, O’Neill WW, et al. Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization. Am J Cardiol. 1985;55(1):188–93.CrossRefPubMed
16.
Zurück zum Zitat Bates ER, Vogel RA, LeFree MT, Kirlin PC, O’Neill WW, Pitt B. The chronic coronary flow reserve provided by saphenous vein bypass grafts as determined by digital coronary radiography. Am Heart J. 1984;108:462–8.CrossRefPubMed Bates ER, Vogel RA, LeFree MT, Kirlin PC, O’Neill WW, Pitt B. The chronic coronary flow reserve provided by saphenous vein bypass grafts as determined by digital coronary radiography. Am Heart J. 1984;108:462–8.CrossRefPubMed
17.
Zurück zum Zitat Simon R, Herrmann G, Amende I. Comparison of three different principles in the assessment of coronary flow reserve from digital angiograms. Int J Card Imaging. 1990;5(2–3):203–12.CrossRefPubMed Simon R, Herrmann G, Amende I. Comparison of three different principles in the assessment of coronary flow reserve from digital angiograms. Int J Card Imaging. 1990;5(2–3):203–12.CrossRefPubMed
18.
Zurück zum Zitat Ionita CN, Garcia VL, Bednarek DR, Snyder KV, Siddiqui AH, Levy EI, et al. Effect of injection technique on temporal parametric imaging derived from digital subtraction angiography in patient specific phantoms. Proc SPIE Int Soc Opt Eng. 2014;13(9038):90380L. Ionita CN, Garcia VL, Bednarek DR, Snyder KV, Siddiqui AH, Levy EI, et al. Effect of injection technique on temporal parametric imaging derived from digital subtraction angiography in patient specific phantoms. Proc SPIE Int Soc Opt Eng. 2014;13(9038):90380L.
19.
Zurück zum Zitat Kennedy AS, Kleinstreuer C, Basciano CA, Dezarn WA. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes. Int J Radiat Oncol Biol Phys. 2010;76(2):631–7.CrossRefPubMed Kennedy AS, Kleinstreuer C, Basciano CA, Dezarn WA. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes. Int J Radiat Oncol Biol Phys. 2010;76(2):631–7.CrossRefPubMed
20.
Zurück zum Zitat Ersahin A, Molloi SY, Hicks JW. Absolute phasic blood flow measurement in the brain using digital subtraction angiography. Invest Radiol. 1995;30(4):244–53.CrossRefPubMed Ersahin A, Molloi SY, Hicks JW. Absolute phasic blood flow measurement in the brain using digital subtraction angiography. Invest Radiol. 1995;30(4):244–53.CrossRefPubMed
21.
Zurück zum Zitat Bonnefous O, Pereira VM, Ouared R, Brina O, Aerts H, Hermans R, et al. Quantification of arterial flow using digital subtraction angiography. Med Phys. 2012;39(10):6264–75.CrossRefPubMed Bonnefous O, Pereira VM, Ouared R, Brina O, Aerts H, Hermans R, et al. Quantification of arterial flow using digital subtraction angiography. Med Phys. 2012;39(10):6264–75.CrossRefPubMed
Metadaten
Titel
Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis
Publikationsdatum
02.08.2016
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 11/2016
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1421-3

Weitere Artikel der Ausgabe 11/2016

CardioVascular and Interventional Radiology 11/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.